AVTX

NASDAQStock

Avalo Therapeutics, Inc.

$15.90-0.81 (-4.85%)

52-Week Range

$3.59

$19.95

Key Stats

Market Cap

179.6M

P/E Ratio

—

Dividend Yield

—

Beta

0.89

Volume

261.5K

Avg Volume

684.0K

Performance

+17.18%

-5.59%

+71.21%

YTD

-1.82%

+117.30%

-97.26%

-99.80%

Price Chart

ETF Exposure

AVTX is held by 11 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
MEDI	Harbor Health Care ETF (MEDI)	0.62%	10,218	$175K	$27.7M	0.80%
IWC	iShares Micro-Cap ETF	0.04%	28,127	$481K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	155,629	$2.4M	$84.10B	0.05%
DFAS	Dimensional - US Small Cap ETF	0.00%	9,276	$155K	$12.65B	0.26%
DXUV	Dimensional - US Vector Equity ETF	0.00%	140	$2K	$351.7M	0.28%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	26	$541	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	944	$19K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	4	$93	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	537,792	$8.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,828	$58K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	243	$5K	$1.29B	0.17%

About AVTX ETF Exposure

Avalo Therapeutics, Inc. (AVTX) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 179.6M, AVTX is a widely held institutional stock. The stock currently trades at $15.90. Investors can gain exposure to AVTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AVTX, sorted by portfolio weight.